Brain scans find early energy changes in MS nerve tissue

Credibility

Interest

Share:1 min read

Key Takeaway

Brain scans found changes in how nerve tissue uses energy early in MS, with larger changes in people who had more disability.

What They Found

Researchers compared brain scans from people with MS and people without MS. Tissue that looked normal on scans used more sugar and less oxygen in people newly diagnosed with MS. This change was greater in people who had lived with MS longer or had more disability. Among newly diagnosed people, different MS treatments affected sugar use differently. Changes inside visible areas of damage were linked to inflammation, but changes in tissue that looked normal were not.

Who Should Care and Why

The study included people with relapsing MS, people with non-relapsing MS, and people without MS. It looked at energy use in the brain, including tissue that appeared normal on scans. Changes were present early in MS. Larger changes were seen with longer disease duration and greater disability. The findings describe a pattern in brain scans, not a new test for disability.

Important Considerations

You should know this was a small study of 45 people. Some participants with relapsing MS had scans before and after starting treatment. The abstract does not name those treatments or show whether changing energy use prevents disability.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Progression

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News